» Articles » PMID: 28657129

Acetyl-CoA Production from Pyruvate is Not Necessary for Preservation of Myelin

Overview
Journal Glia
Specialty Neurology
Date 2017 Jun 29
PMID 28657129
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Oligodendrocytes and Schwann cells not only form myelin in the central and peripheral nervous system, but also provide metabolic and trophic support to the axons they ensheathe. Acetyl-CoA is potentially a key molecule in Schwann cells and oligodendrocytes because it is at the crossroads of cellular lipid biosynthesis and energy generation. The main route for acetyl-CoA production is the oxidation of pyruvate by the pyruvate dehydrogenase complex (PDC). PDC deficiency in humans results in neurodegeneration and developmental impairments in both white and gray matter structures. To address the importance of PDC in myelinating glia, we deleted Pdha1 gene specifically in oligodendrocytes and Schwann cells. Surprisingly, sciatic and optic nerve morphology and the motor performance of Pdha1 Cnp mice are undistinguishable from those of controls at 1 month of age. In addition, myelin is stably maintained for at least 10 months. However, Pdha1 Cnp mice showed reduced fiber density and signs of axonal degeneration in both sciatic and optic nerves from 6 months of age. In contrast, 10 month-old mice bearing a floxed Pdha1 gene with either P0-Cre (expressed only by Schwann cells) or NG2-Cre (expressed in oligodendrocyte precursor cells) do not show any sign of axonal pathology or alterations in myelin structure or thickness. This indicates that the axonopathy is specific to the Pdha1 Cnp mice. Taken together, these results suggest that acetyl-CoA derived from pyruvate is not necessary for myelin maintenance and, thus, myelin-forming cells are not likely to contribute to the pathophysiology of PDC deficiency.

Citing Articles

The role of ATP citrate lyase in myelin formation and maintenance.

Schneider A, Won S, Armstrong E, Cooper A, Suresh A, Rivera R Glia. 2024; 73(1):105-121.

PMID: 39318247 PMC: 11660526. DOI: 10.1002/glia.24620.


PMP2 regulates myelin thickening and ATP production during remyelination.

Hong J, Garfolo R, Kabre S, Humml C, Velanac V, Roue C Glia. 2024; 72(5):885-898.

PMID: 38311982 PMC: 11027087. DOI: 10.1002/glia.24508.


Pyruvate Dehydrogenase-Dependent Metabolic Programming Affects the Oligodendrocyte Maturation and Remyelination.

Sajad M, Zahoor I, Rashid F, Cerghet M, Rattan R, Giri S Mol Neurobiol. 2023; 61(1):397-410.

PMID: 37620688 DOI: 10.1007/s12035-023-03546-x.


Non-Targeted Metabolic Profiling of Cerebellum in Spina Bifida Fetal Rats.

Thielen E, Oria M, Watanabe-Chailland M, Lampe K, Romick-Rosendale L, Peiro J Metabolites. 2023; 13(5).

PMID: 37233711 PMC: 10223940. DOI: 10.3390/metabo13050670.


Coordinated Regulation of Myelination by Growth Factor and Amino-acid Signaling Pathways.

Yang Z, Yu Z, Xiao B Neurosci Bull. 2022; 39(3):453-465.

PMID: 36352321 PMC: 10043148. DOI: 10.1007/s12264-022-00967-x.


References
1.
Siess E, Wittmann J, Wieland O . Interconversion and kinetic properties of pyruvate dehydrogenase from brain. Hoppe Seylers Z Physiol Chem. 1971; 352(3):447-52. DOI: 10.1515/bchm2.1971.352.1.447. View

2.
Berger P, Niemann A, Suter U . Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Glia. 2006; 54(4):243-57. DOI: 10.1002/glia.20386. View

3.
Edmond J, Robbins R, Bergstrom J, Cole R, de Vellis J . Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res. 1987; 18(4):551-61. DOI: 10.1002/jnr.490180407. View

4.
Kim S, Maynard J, Sasaki Y, Strickland A, Sherman D, Brophy P . Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity. J Neurosci. 2016; 36(37):9633-46. PMC: 5039245. DOI: 10.1523/JNEUROSCI.1235-16.2016. View

5.
Viader A, Golden J, Baloh R, Schmidt R, Hunter D, Milbrandt J . Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci. 2011; 31(28):10128-40. PMC: 3147283. DOI: 10.1523/JNEUROSCI.0884-11.2011. View